Diagnosis and Treatment > Signs and Symptoms
Search for other papers by Annika Sjoeholm in
Google Scholar
PubMed
Search for other papers by Cassandra Li in
Google Scholar
PubMed
Search for other papers by Chaey Leem in
Google Scholar
PubMed
Search for other papers by Aiden Lee in
Google Scholar
PubMed
Search for other papers by Maria P Stack in
Google Scholar
PubMed
Search for other papers by Paul L Hofman in
Google Scholar
PubMed
Paediatric Endocrinology, Southern District Health Board, Dunedin, New Zealand
Search for other papers by Benjamin J Wheeler in
Google Scholar
PubMed
Summary
Phaeochromocytomas are a rare clinical entity, with dual hormone-secreting lesions particularly uncommon, seen in <1%. ACTH is the most common hormone co-produced, and is potentially lethal if not diagnosed. We present the case of a previously well 10-year-old boy, who presented acutely with a hypertensive crisis and was found to have a unilateral, non-syndromic phaeochromocytoma. Medical stabilization of his hypertension was challenging, and took 3 weeks to achieve, before proceeding to unilateral adrenalectomy. Post-operatively the child experienced severe fatigue and was subsequently confirmed to have adrenal insufficiency. He improved markedly with hydrocortisone replacement therapy, which is ongoing 6 months post-operatively. In retrospect this likely represents unrecognized, sub-clinical ACTH-dependent Cushing's syndrome secondary to an ACTH/or precursor dual-hormone secreting phaeochromocytoma. At follow-up, his hypertension had resolved, there was no biochemical evidence of recurrence of the phaeochromocytoma, and genetic analysis was indicative of a sporadic lesion.
Learning points
-
Dual hormone secreting phaeochromocytomas with ACTH/or a precursor may cause secondary adrenal insufficiency following surgical removal.
-
The concurrent features of Cushing's syndrome can be mild and easily overlooked presenting diagnostic and management pitfalls.
-
As concomitant syndromes of hormone excess are rare in phaeochromocytomas; the diagnosis requires a high index of suspicion.
-
Serial/diurnal cortisol levels, ACTH measurement +/− low dose dexamethasone suppression (when clinically stable, appropriate adrenergic blockade in place, and well supervised), can all be considered as needed.
Search for other papers by Ramez Ibrahim in
Google Scholar
PubMed
Search for other papers by Atul Kalhan in
Google Scholar
PubMed
Search for other papers by Alistair Lammie in
Google Scholar
PubMed
Search for other papers by Christine Kotonya in
Google Scholar
PubMed
Search for other papers by Ravindra Nannapanenni in
Google Scholar
PubMed
Search for other papers by Aled Rees in
Google Scholar
PubMed
Summary
A 30-year-old female presented with a history of secondary amenorrhoea, acromegalic features and progressive visual deterioration. She had elevated serum IGF1 levels and unsuppressed GH levels after an oral glucose tolerance test. Magnetic resonance imaging revealed a heterogeneously enhancing space-occupying lesion with atypical extensive calcification within the sellar and suprasellar areas. Owing to the extent of calcification, the tumour was a surgical challenge. Postoperatively, there was clinical, radiological and biochemical evidence of residual disease, which required treatment with a somatostatin analogue and radiotherapy. Mutational analysis of the aryl hydrocarbon receptor-interacting protein (AIP) gene was negative. This case confirms the relatively rare occurrence of calcification within a pituitary macroadenoma and its associated management problems. The presentation, biochemical, radiological and pathological findings are discussed in the context of the relevant literature.
Learning points
-
Calcification of pituitary tumours is relatively rare.
-
Recognising calcification in pituitary adenomas on preoperative imaging is important in surgical decision-making.
-
Gross total resection can be difficult to achieve in the presence of extensive calcification and dictates further management and follow-up to achieve disease control.
